Premium
Biogenic amine metabolites in the CSF of patients with late onset and alcoholic ataxias
Author(s) -
Kaakkola S.,
Tuomainen P.,
Männistö P. T.,
Palo J.
Publication year - 1993
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1993.tb05513.x
Subject(s) - homovanillic acid , ataxia , cerebrospinal fluid , biogenic amine , dopamine , monoamine neurotransmitter , medicine , endocrinology , chemistry , psychology , anesthesia , central nervous system , serotonin , psychiatry , neurotransmitter , receptor
The levels of monoamine metabolites 3,4‐dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 3‐methoxy‐4‐hydroxyphenylglycol (MHPG) and 5‐hydroxyindoleacetic acid (5‐HIAA) were measured in lumbar cerebrospinal fluid (CSF) from 10 patients with late onset ataxia, 8 patients with alcoholic ataxia and 18 control patients. The levels did not differ significantly among the three groups of patients suggesting that the central neuronal systems utilizing dopamine, noradrenaline and 5‐hydroxytryptamine do not have a significant pathophysiological role in these forms of ataxias. The measurement of CSF amine metabolites probably does not contribute to the differential diagnosis of ataxias.